Axsome Therapeutics’ (AXSM) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $200.00 price objective on the stock. A number of other research firms have also weighed in on AXSM. Cantor Fitzgerald reissued an “overweight” rating and issued […]
HC Wainwright reissued their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $200.00 price objective on the stock. A number of other research firms have also weighed in on AXSM. Cantor Fitzgerald reissued an “overweight” rating and issued […]
